564 related articles for article (PubMed ID: 19692240)
21. Aryloxy cyclohexyl imidazoles: a novel class of antileishmanial agents.
Srinivas N; Palne S; Nishi ; Gupta S; Bhandari K
Bioorg Med Chem Lett; 2009 Jan; 19(2):324-7. PubMed ID: 19091566
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and antileishmanial activity of some 1- or 2-(dihydroxyalkyl) and 3-(dihydroxyalkoxy)pyrazolo [3,4-d] pyrimidines.
Gatta F; Gradoni L; Lupardini E; Gramiccia M; Orsini S
Farmaco; 1991 Jan; 46(1):75-84. PubMed ID: 2054043
[TBL] [Abstract][Full Text] [Related]
23. Biomimetic synthesis, antimicrobial, antileishmanial and antimalarial activities of euglobals and their analogues.
Bharate SB; Bhutani KK; Khan SI; Tekwani BL; Jacob MR; Khan IA; Singh IP
Bioorg Med Chem; 2006 Mar; 14(6):1750-60. PubMed ID: 16274995
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and in vitro leishmanicidal activity of 2-(1-methyl-5-nitro-1H-imidazol-2-yl)-5-substituted-1,3,4-thiadiazole derivatives.
Foroumadi A; Emami S; Pournourmohammadi S; Kharazmi A; Shafiee A
Eur J Med Chem; 2005 Dec; 40(12):1346-50. PubMed ID: 16095763
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani.
Keurulainen L; Siiskonen A; Nasereddin A; Kopelyanskiy D; Sacerdoti-Sierra N; Leino TO; Tammela P; Yli-Kauhaluoma J; Jaffe CL; Kiuru P
Bioorg Med Chem Lett; 2015 May; 25(9):1933-7. PubMed ID: 25827525
[TBL] [Abstract][Full Text] [Related]
26. Triazino indole-quinoline hybrid: a novel approach to antileishmanial agents.
Sharma R; Pandey AK; Shivahare R; Srivastava K; Gupta S; Chauhan PM
Bioorg Med Chem Lett; 2014 Jan; 24(1):298-301. PubMed ID: 24314395
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of 2-(pyrimidin-2-yl)-1-phenyl-2,3,4,9-tetrahydro-1H-beta-carbolines as antileishmanial agents.
Kumar R; Khan S; Verma A; Srivastava S; Viswakarma P; Gupta S; Meena S; Singh N; Sarkar J; Chauhan PM
Eur J Med Chem; 2010 Aug; 45(8):3274-80. PubMed ID: 20457476
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antikinetoplastid activities of 3-substituted quinolinones derivatives.
Audisio D; Messaoudi S; Cojean S; Peyrat JF; Brion JD; Bories C; Huteau F; Loiseau PM; Alami M
Eur J Med Chem; 2012 Jun; 52():44-50. PubMed ID: 22472166
[TBL] [Abstract][Full Text] [Related]
29. Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series.
Kieffer C; Cohen A; Verhaeghe P; Hutter S; Castera-Ducros C; Laget M; Remusat V; M'Rabet MK; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2015 Mar; 92():282-94. PubMed ID: 25559208
[TBL] [Abstract][Full Text] [Related]
30. Antileishmanial 2-substituted quinolines: in vitro behaviour towards biological components.
Desrivot J; Herrenknecht C; Ponchel G; Garbi N; Prina E; Fournet A; Bories C; Figadère B; Hocquemiller R; Loiseau PM
Biomed Pharmacother; 2007 Aug; 61(7):441-50. PubMed ID: 17459651
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of 2-pyridyl pyrimidines with in vitro antiplasmodial and antileishmanial activity.
Musonda CC; Whitlock GA; Witty MJ; Brun R; Kaiser M
Bioorg Med Chem Lett; 2009 Jan; 19(2):401-5. PubMed ID: 19091562
[TBL] [Abstract][Full Text] [Related]
32. Arylanthranilodinitriles: a new biaryl class of antileishmanial agents.
Singh FV; Vatsyayan R; Roy U; Goel A
Bioorg Med Chem Lett; 2006 May; 16(10):2734-7. PubMed ID: 16503140
[TBL] [Abstract][Full Text] [Related]
33. Structurally diverse 5-substituted pyrimidine nucleosides as inhibitors of Leishmania donovani promastigotes in vitro.
Torrence PF; Fan X; Zhang X; Loiseau PM
Bioorg Med Chem Lett; 2006 Oct; 16(19):5047-51. PubMed ID: 16879965
[TBL] [Abstract][Full Text] [Related]
34. Diastereoselective synthesis of substituted hexahydrobenzo[de]isochromanes and evaluation of their antileishmanial activity.
Saikia AK; Sultana S; Devi NR; Deka MJ; Tiwari K; Dubey VK
Org Biomol Chem; 2016 Jan; 14(3):970-9. PubMed ID: 26625982
[TBL] [Abstract][Full Text] [Related]
35. [Antileishmanial activity of five 2- or 3- quinolines by enyne group].
Seck M; Desrivot J; Bories C; Loiseau P; Franck X; Hocquemiller R; Figadere B; Peyrat JF; Provot O; Brion JD; Alami M
Dakar Med; 2005; 50(3):172-5. PubMed ID: 17633005
[TBL] [Abstract][Full Text] [Related]
36. A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity.
Guglielmo S; Bertinaria M; Rolando B; Crosetti M; Fruttero R; Yardley V; Croft SL; Gasco A
Eur J Med Chem; 2009 Dec; 44(12):5071-9. PubMed ID: 19811859
[TBL] [Abstract][Full Text] [Related]
37. Analysis of stereoelectronic properties, mechanism of action and pharmacophore of synthetic indolo[2,1-b]quinazoline-6,12-dione derivatives in relation to antileishmanial activity using quantum chemical, cyclic voltammetry and 3-D-QSAR CATALYST procedures.
Bhattacharjee AK; Skanchy DJ; Jennings B; Hudson TH; Brendle JJ; Werbovetz KA
Bioorg Med Chem; 2002 Jun; 10(6):1979-89. PubMed ID: 11937358
[TBL] [Abstract][Full Text] [Related]
38. In pursuit of natural product leads: synthesis and biological evaluation of 2-[3-hydroxy-2-[(3-hydroxypyridine-2-carbonyl)amino]phenyl]benzoxazole-4-carboxylic acid (A-33853) and its analogues: discovery of N-(2-benzoxazol-2-ylphenyl)benzamides as novel antileishmanial chemotypes.
Tipparaju SK; Joyasawal S; Pieroni M; Kaiser M; Brun R; Kozikowski AP
J Med Chem; 2008 Dec; 51(23):7344-7. PubMed ID: 18989953
[TBL] [Abstract][Full Text] [Related]
39. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes.
Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN
Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660
[TBL] [Abstract][Full Text] [Related]
40. Discovery of a new antileishmanial hit in 8-nitroquinoline series.
Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P
Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
